Faculty profile

Sandra Cohen

ResearcherMedicineUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Sandra Cohen

Researcher

Medicine

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
9 publications in the last five years, latest in 2025.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2014.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cord Blood Transplantation Fed Batch Culture System Hematopoietic Stem Cell Expansion Novel Agonist Of Stem Cell Renewal Phase I Clinical Study

Latest papers

Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry.
Transplantation and cellular therapy · 2025 · first author
Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient.
Hematology (Amsterdam, Netherlands) · 2025
Corrigendum to' UM171 expansion of cord blood improves donor availability and HLA matching for all patients, including minorities' [Transplantation and Cellular Therapy 28/7 (2022) 410-410.
Transplantation and cellular therapy · 2024 · senior author

All 22 publications

Latest funding

Clinical application of a novel molecule that expands human cord blood stem cells
CIHR · 2014 · Principal investigator
$1,013,167

All 1 grants and awards

22 publications.

Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry.

Cohen S, Labopin M, Bambace N, Ahmad I, Dumont-Lagacé M, Ciceri F, McLornan DP, Labussière-Wallet H, Kröger N, de Latour RP, Chalandon Y, Forcade E, Cluzeau T, Jindra P, Kulagin A, Roy J, Lachance S, Barabé F, Caudrelier P, Sauvageau G, Yakoub-Agha I, Mohty M

Transplantation and cellular therapy2025First author

DOI: 10.1016/j.jtct.2025.08.006 PMID: 40818826

Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient.

Tanguay M, Cohen S, Ménard I, Meunier MC, Delisle JS, Roy J, Veilleux O, Ahmad I

Hematology (Amsterdam, Netherlands)2025

DOI: 10.1080/16078454.2024.2448552 PMID: 39763113

Corrigendum to' UM171 expansion of cord blood improves donor availability and HLA matching for all patients, including minorities' [Transplantation and Cellular Therapy 28/7 (2022) 410-410.

Dumont-Lagacé M, Feghaly A, Meunier MC, Finney M, Van't Hof W, Frenet EM, Sauvageau G, Cohen S

Transplantation and cellular therapy2024Senior author

DOI: 10.1016/j.jtct.2023.08.024 PMID: 37726096

Towards clinically meaningful expansion of human HSCs.

Tellechea MF, Chagraoui J, Cohen S, Sauvageau G

Cell research2023

DOI: 10.1038/s41422-023-00817-z PMID: 37161072

International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant.

Garcia-Rosa M, Abraham A, Bertaina A, Bhoopalan SV, Bonfim C, Cohen S, DeZern A, Louis C, Oved J, Pavel-Dinu M, Purtill D, Ruggeri A, Russell A, Sharma A, Wynn R, Boelens JJ, Prockop S

Cytotherapy2023

DOI: 10.1016/j.jcyt.2023.02.007 PMID: 36941149

Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.

Lachance S, Bourguignon A, Boisjoly JA, Bouchard P, Ahmad I, Bambace N, Bernard L, Cohen S, Delisle JS, Fleury I, Kiss T, Mollica L, Roy DC, Sauvageau G, Veilleux O, Zehr J, Chagnon M, Roy J

Transplantation and cellular therapy2023

DOI: 10.1016/j.jtct.2022.10.003 PMID: 36243319

Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Kadri Y, Phan M, Bambace N, Bernard L, Cohen S, Delisle JS, Kiss T, Lachance S, Roy DC, Sauvageau G, Veilleux O, Roy J, Ahmad I

Current oncology (Toronto, Ont.)2022

DOI: 10.3390/curroncol29080470 PMID: 36005208

UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities.

Dumont-Lagacé M, Feghaly A, Meunier MC, Finney M, Van't Hof W, Masson Frenet E, Sauvageau G, Cohen S

Transplantation and cellular therapy2022Senior author

DOI: 10.1016/j.jtct.2022.03.016 PMID: 35311667

Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study.

LeBlanc R, Ahmad I, Terra R, Boudreault JS, Ogez D, Lamore K, Delisle JS, Bambace N, Bernard L, Cohen S, Kiss T, Lachance S, Landais S, Lemieux-Blanchard É, Sauvageau G, Sebag M, Roy DC, Roy J

Bone marrow transplantation2022

DOI: 10.1038/s41409-021-01532-2 PMID: 34845367

UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe Infections.

Dumont-Lagacé M, Li Q, Tanguay M, Chagraoui J, Kientega T, Cardin GB, Brasey A, Trofimov A, Carli C, Ahmad I, Bambace NM, Bernard L, Kiss TL, Roy J, Roy DC, Lemieux S, Perreault C, Rodier F, Dufresne SF, Busque L, Lachance S, Sauvageau G, Cohen S, Delisle JS

Transplantation and cellular therapy2021

DOI: 10.1016/j.bbmt.2020.09.031 PMID: 33022376

Something wrong or missing on this profile? Suggest a correction

Sandra Cohen

Research

Latest papers

Latest funding

Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry.

Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient.

Corrigendum to' UM171 expansion of cord blood improves donor availability and HLA matching for all patients, including minorities' [Transplantation and Cellular Therapy 28/7 (2022) 410-410.

Towards clinically meaningful expansion of human HSCs.

International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant.

Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.

Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.

UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities.

Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study.

UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe Infections.

Clinical application of a novel molecule that expands human cord blood stem cells

Frequent collaborators

Guy Sauvageau

Jean Roy

Denis-Claude Roy

Lambert Busque

Claude Perreault

Anne Marinier

John Kim

Mitchell Sabloff

Francis Rodier

John Kuruvilla

David Ogez

Tony Panzarella

Ronan Foley

Michael Sebag